Key regions: Australia, Brazil, United Kingdom, Europe, Canada
Other Vaccines market in Slovenia has been showing a positive trend in recent years. Slovenia is a small country located in Central Europe, bordered by Italy, Austria, Hungary, and Croatia. The country has a population of around 2 million people, with a well-developed healthcare system.
Customer preferences: Slovenia has a high vaccination rate, with a majority of the population vaccinated against common diseases. The government plays a significant role in promoting vaccination, and the healthcare system provides vaccines free of charge for children and adults.
Trends in the market: The Other Vaccines market in Slovenia is growing due to the increasing awareness of vaccination and the introduction of new vaccines. The demand for vaccines against infectious diseases such as HPV, hepatitis A and B, and meningococcal disease is increasing. The market is also seeing a rise in demand for travel vaccines as more people travel abroad.
Local special circumstances: Slovenia has a well-established healthcare system with a high level of healthcare services. The country has a strong pharmaceutical industry, and many global pharmaceutical companies have operations in Slovenia. The government provides support for research and development in the pharmaceutical industry, which has led to the development of new vaccines.
Underlying macroeconomic factors: Slovenia has a stable and growing economy, with a GDP growth rate of around 4% in recent years. The country has a high standard of living and a well-educated population. The healthcare system in Slovenia is well-funded, and the government provides support for healthcare services. These factors have contributed to the growth of the Other Vaccines market in Slovenia. In conclusion, the Other Vaccines market in Slovenia is growing due to the increasing awareness of vaccination, the introduction of new vaccines, and the support from the government for the pharmaceutical industry. The country's stable and growing economy, high standard of living, and well-developed healthcare system have also contributed to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
